Evidence map›Paper›PMID 41596233›Full record

ArticleInternational journal of molecular sciences2026

A Comprehensive Physicochemical Analysis Focusing on the Characterization and Stability of Valsartan Silver Nano-Conjugates.

Abdul Qadir, Khwaja Suleman Hasan, Khair Bux, Khwaja Ali Hasan, Aamir Jalil, Asad Khan Tanoli, Khwaja Akbar Hasan, Shahida Naz, Muhammad Kashif, Nuzhat Fatima Zaidi and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Abdul QadirMolecular and Structural Biochemistry Research Unit, Department of Biochemistry, University of Karachi, Karachi 75270, Pakistan.ORCID 0009-0000-2508-8561
Khwaja Suleman HasanDepartment of Chemistry, University of Karachi, Karachi 75270, Pakistan.
Khair BuxDepartment of Biosciences, Faculty of Life Sciences, Shaheed Zulfiqar Ali Bhutto Institute of Science and Technology (SZABIST), Karachi 75600, Pakistan.ORCID 0000-0003-2440-0116
Khwaja Ali HasanMolecular and Structural Biochemistry Research Unit, Department of Biochemistry, University of Karachi, Karachi 75270, Pakistan.ORCID 0000-0002-5177-7923
Aamir JalilDepartment of Pharmaceutical Sciences, Bahauddin Zakaria University, Multan 60800, Pakistan.
Asad Khan TanoliDepartment of Chemistry, University of Karachi, Karachi 75270, Pakistan.
Khwaja Akbar HasanDepartment of Chemistry, University of Karachi, Karachi 75270, Pakistan.
Shahida NazMolecular and Structural Biochemistry Research Unit, Department of Biochemistry, University of Karachi, Karachi 75270, Pakistan.
Muhammad KashifInstitute of Chemistry, Shah Abdul Latif University Khairpur, Khairpur 66020, Pakistan.
Nuzhat Fatima ZaidiClinical Biochemistry and Hematology Research Laboratory, Department of Biochemistry, Federal Urdu University, Karachi 75300, Pakistan.
Ayesha KhanDepartment of Biochemistry, University of Karachi, Karachi 75270, Pakistan.
Zeeshan VohraInternational Center for Chemical and Biological Sciences (ICCBS), H.E.J. Research Institute of Chemistry, University of Karachi, Karachi 75270, Pakistan.
Herwig RalfLaboratories PD Dr. R. Herwig, 80337 Munich, Germany.
Shama QaiserAga Khan University Hospital, Karachi 74800, Pakistan.

Funding

University of Karachi UOK to K.A. HASAN (DFS/2021-2022/CH.NO.270099441)
6 · The paper itself

Abstract

Valsartan (Val)-a lipophilic non-peptide angiotensin II type 1 receptor antagonist-is highly effective against hypertension and displaying limited solubility in water (3.08 μg/mL), thereby resulting in low oral bioavailability (23%). The limited water solubility of antihypertensive drugs can pose a challenge, particularly for rapid and precise administration. Herein, we synthesize and characterize valsartan-containing silver nanoparticles (Val-AgNPs) using

Indexed as

Metal NanoparticlesSilverValsartanAntihypertensive AgentsCalorimetry, Differential ScanningDrug StabilityParticle SizeSolubilitySpectroscopy, Fourier Transform InfraredAntihypertensive AgentsSilverValsartandifferential scanning calorimetryhemocompatibilityMangifera indicanano-conjugationsolubilityvalsartan

Identifiers

PMID41596233
PMCPMC12841268

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.